A detailed history of Destination Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Destination Wealth Management holds 2,004 shares of ABBV stock, worth $330,639. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,004
Previous 1,585 26.44%
Holding current value
$330,639
Previous $288,000 19.1%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$154.79 - $180.76 $64,857 - $75,738
419 Added 26.44%
2,004 $343,000
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $53,699 - $61,185
-336 Reduced 17.49%
1,585 $288,000
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $14,448 - $16,271
105 Added 5.78%
1,921 $297,000
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $3,072 - $3,556
-23 Reduced 1.25%
1,816 $270,000
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $79,638 - $99,104
-601 Reduced 24.63%
1,839 $247,000
Q1 2023

May 05, 2023

BUY
$144.61 - $166.54 $88,935 - $102,422
615 Added 33.7%
2,440 $388,000
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $113,275 - $135,847
-819 Reduced 30.98%
1,825 $295,000
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $68,581 - $78,658
-511 Reduced 16.2%
2,644 $355,000
Q2 2022

Jul 29, 2022

SELL
$137.62 - $174.96 $6,743 - $8,573
-49 Reduced 1.53%
3,155 $483,000
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $53,055 - $65,827
-402 Reduced 11.15%
3,204 $519,000
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $150,509 - $190,437
1,401 Added 63.54%
3,606 $488,000
Q3 2021

Oct 25, 2021

SELL
$106.4 - $120.78 $41,176 - $46,741
-387 Reduced 14.93%
2,205 $238,000
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $124,884 - $139,128
-1,187 Reduced 31.41%
2,592 $292,000
Q1 2021

May 05, 2021

BUY
$102.3 - $112.62 $189,357 - $208,459
1,851 Added 96.01%
3,779 $409,000
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $155,184 - $209,515
1,928 New
1,928 $207,000
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $232,216 - $310,739
-3,165 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $289,605 - $439,077
-4,490 Reduced 58.65%
3,165 $241,000
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $35,199 - $44,042
488 Added 6.81%
7,655 $678,000
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $6.07 Million - $7.3 Million
-96,443 Reduced 93.08%
7,167 $543,000
Q2 2019

Jul 19, 2019

SELL
$65.7 - $83.98 $13.5 Million - $17.3 Million
-205,417 Reduced 66.47%
103,610 $7.54 Million
Q1 2019

May 01, 2019

BUY
$77.14 - $90.79 $1.04 Million - $1.23 Million
13,536 Added 4.58%
309,027 $24.9 Million
Q4 2018

Feb 05, 2019

BUY
$77.85 - $96.01 $547,129 - $674,758
7,028 Added 2.44%
295,491 $27.2 Million
Q3 2018

Nov 07, 2018

BUY
$88.91 - $98.84 $366,931 - $407,912
4,127 Added 1.45%
288,463 $27.3 Million
Q2 2018

Jul 31, 2018

BUY
$89.78 - $106.23 $145,353 - $171,986
1,619 Added 0.57%
284,336 $26.3 Million
Q1 2018

Apr 05, 2018

SELL
$92.01 - $123.21 $3.48 Million - $4.66 Million
-37,835 Reduced 11.8%
282,717 $26.8 Million
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $2.89 Million - $3.17 Million
-32,306 Reduced 9.16%
320,552 $31 Million
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $34,785 - $44,431
498 Added 0.14%
352,858 $31.4 Million
Q2 2017

Aug 11, 2017

BUY
N/A
352,360
352,360 $25.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Destination Wealth Management Portfolio

Follow Destination Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Destination Wealth Management with notifications on news.